Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02399215 |
Title | Nintedanib in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors |
Recruitment | Completed |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Roswell Park Cancer Institute |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |